For over 20 years, Salix Pharmaceuticals, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. has been committed to providing solutions for the management of many chronic and debilitating conditions. Salix currently markets products to U.S. healthcare providers in the areas of gastroenterology,hepatology,internal medicine,primary care,infectious disease, and allergy/immunology